Cancer of unknown primary origin: a case report

Carcinoma of unknown primary origin (CUP) accounts for 2-10% of all malignancies. The apparent absence of the primary tumour, the development of early, uncommon systemic metastases and the resistance to therapy and poor prognosis are hallmarks of this heterogeneous clinical entity and are a challeng...

Full description

Bibliographic Details
Main Authors: Elisa De Carlo, Ciro Rossetto, Gianpiero Fasola
Format: Article
Language:English
Published: SEEd 2013-03-01
Series:Clinical Management Issues
Subjects:
Online Access:https://journals.seedmedicalpublishers.com/index.php/cmi/article/view/639
id doaj-111c6d0eae22412a870f2b43a65145c1
record_format Article
spelling doaj-111c6d0eae22412a870f2b43a65145c12020-11-25T00:40:18ZengSEEdClinical Management Issues1973-48322283-31372013-03-0171273410.7175/cmi.v7i1.639609Cancer of unknown primary origin: a case reportElisa De Carlo0Ciro Rossetto1Gianpiero Fasola2Dipartimento di oncologia. Azienda Ospedaliero Universitaria di UdineDipartimento di oncologia. Azienda Ospedaliero Universitaria di UdineDipartimento di oncologia. Azienda Ospedaliero Universitaria di UdineCarcinoma of unknown primary origin (CUP) accounts for 2-10% of all malignancies. The apparent absence of the primary tumour, the development of early, uncommon systemic metastases and the resistance to therapy and poor prognosis are hallmarks of this heterogeneous clinical entity and are a challenge for physicians. The diagnostic workup of patients with CUP includes a large amount of histopathological examination, as well as the use of imaging techniques that often fail to identify the primary tumour. Therefore, the optimal workup and treatment for these patients remains to be determined. Molecular diagnostic tools, such as DNA microarray analysis, could help in the search for "lost" CUP origin and guide the further treatment approach. We report the case of a 66-year-old man, with mediastinal lymph nodes metastasis of carcinoma and neurological syndrome with diplopia and balance disorders, in which many exams have been performed without finding the primary tumour.https://journals.seedmedicalpublishers.com/index.php/cmi/article/view/639Cancer of unknown primary, immunohistochemistry, therapeutic management
collection DOAJ
language English
format Article
sources DOAJ
author Elisa De Carlo
Ciro Rossetto
Gianpiero Fasola
spellingShingle Elisa De Carlo
Ciro Rossetto
Gianpiero Fasola
Cancer of unknown primary origin: a case report
Clinical Management Issues
Cancer of unknown primary, immunohistochemistry, therapeutic management
author_facet Elisa De Carlo
Ciro Rossetto
Gianpiero Fasola
author_sort Elisa De Carlo
title Cancer of unknown primary origin: a case report
title_short Cancer of unknown primary origin: a case report
title_full Cancer of unknown primary origin: a case report
title_fullStr Cancer of unknown primary origin: a case report
title_full_unstemmed Cancer of unknown primary origin: a case report
title_sort cancer of unknown primary origin: a case report
publisher SEEd
series Clinical Management Issues
issn 1973-4832
2283-3137
publishDate 2013-03-01
description Carcinoma of unknown primary origin (CUP) accounts for 2-10% of all malignancies. The apparent absence of the primary tumour, the development of early, uncommon systemic metastases and the resistance to therapy and poor prognosis are hallmarks of this heterogeneous clinical entity and are a challenge for physicians. The diagnostic workup of patients with CUP includes a large amount of histopathological examination, as well as the use of imaging techniques that often fail to identify the primary tumour. Therefore, the optimal workup and treatment for these patients remains to be determined. Molecular diagnostic tools, such as DNA microarray analysis, could help in the search for "lost" CUP origin and guide the further treatment approach. We report the case of a 66-year-old man, with mediastinal lymph nodes metastasis of carcinoma and neurological syndrome with diplopia and balance disorders, in which many exams have been performed without finding the primary tumour.
topic Cancer of unknown primary, immunohistochemistry, therapeutic management
url https://journals.seedmedicalpublishers.com/index.php/cmi/article/view/639
work_keys_str_mv AT elisadecarlo cancerofunknownprimaryoriginacasereport
AT cirorossetto cancerofunknownprimaryoriginacasereport
AT gianpierofasola cancerofunknownprimaryoriginacasereport
_version_ 1725291100788228096